# Oral Tranexamic Acid Plus Triple Combination vs Triple Combination Alone in Melasma

> **NCT07732192** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Combined Military Hospital Abbottabad** · enrollment: 128 (estimated)

## Conditions studied

- Melasma
- Melasma (Facial Melasma)

## Interventions

- **COMBINATION_PRODUCT:** Oral tranexamic acid + triple combination cream (fluocinolone acetonide + hydroquinone + tretinoin)
- **DRUG:** Triple combination cream (fluocinolone acetonide + hydroquinone + tretinoin) alone

## Key facts

- **NCT ID:** NCT07732192
- **Lead sponsor:** Combined Military Hospital Abbottabad
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-15
- **Primary completion:** 2027-01-14
- **Final completion:** 2027-02-01
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2026-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07732192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07732192, "Oral Tranexamic Acid Plus Triple Combination vs Triple Combination Alone in Melasma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07732192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*